Finger-stick glucose monitoring: Issues of accuracy and specificity

Diabetes Care

Volumn 33, Issue 4, 2010, Pages 948-949

  Olansky, Leann ^a   Kennedy, Laurence ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ACCURACY; ANALYTICAL ERROR; DEVICE; DIABETIC PATIENT; EDITORIAL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; SELF MONITORING; SENSITIVITY AND SPECIFICITY;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BLOOD SPECIMEN COLLECTION; FINGERS; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77953064609     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0077     Document Type: Editorial

References (10)

1. International Organization for Standardization. In vitro diagnostic test systems-requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO report 15197. Geneva, Switzerland, International Organization for Standardization, 2003
2. Kost GJ, Tran NK, Abad VJ, Louie RF. Evaluation of point-of-care glucose testing accuracy using locally-smoothed median absolute difference curves. Clin Chim Acta 2008;389:31-39
3. Kimberly MM, Vesper HW, Caudill SP, Ethridge SF, Archibold E, Porter KH, Myers GL. Variability among five over-the-counter blood glucose monitors. Clin Chim Acta 2006;364:292-297
4. Flore KMJ, Fiers T, Delanghe JR. Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment. Clin Chem Lab Med 2008;46:1763-1768
5. Flore KMJ, Delanghe JR. Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int 2009;29:377-383
6. D'Costa EJ, Higgins IJ, Turner APF. Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor. Biosensors 1986;2:71-87
7. Schleis TG. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy 2007;27:1313-1321
8. Kannan S, Rowland CH, Hockings GI, Tauchmann PM. Intragam can interfere with blood glucose monitoring. Med J Aust 2004;180:251-252 (Pubitemid 38312991)
9. U.S. Food and Drug Administration. FDA public health notification: potentially fatal errors with GDH-PDD glucose monitoring technology [Internet], 2009. Available from http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PublicHealthNotifications/ucm176992.htm. Accessed 13 January 2010
10. Frias JP, Lim CG, Ellison JM, Montandon CM. A review of adverse events associated with false glucose readings measured by GDH-PQQ-based glucose test strips in the presence of interfering sugars. Diabetes Care 2010;33:728-729